As a computational epidemiologist who has reviewed for and published in major cardiology journals, I see this pattern frequently. An author submits a technically sound manuscript that, on its face, addresses a topic listed in the journal's aims, only to receive a rapid desk rejection citing "scope mismatch." The frustration is understandable, but the issue is rarely about the broad topic. It's almost always about the angle of the investigation and its perceived contribution to the core conversations happening in clinical cardiology.
In cardiology publishing, "scope" is not a static list of acceptable diseases. It's a dynamic boundary defined by the journal's intended audience—typically, the busy cardiologist or cardiovascular investigator. A scope mismatch occurs when the study's primary takeaway falls outside the immediate clinical or mechanistic interests of that audience, even if the subject matter (e.g., heart failure, atrial fibrillation) is nominally within the journal's purview.
From what I've observed in editorial boards, the most common triggers are:
Let's apply this to the domain corpus provided, which interestingly contains no direct cardiology references. This itself is a clue. Imagine you are studying cardiac manifestations of celiac disease. While the heart can be involved (e.g., cardiomyopathy), a manuscript focusing predominantly on the genetics of celiac pathology or the efficacy of a gluten-free diet on gastrointestinal symptoms will be rejected for scope. The cardiology journal's editor asks: "Does this paper advance the practice of cardiology?" The link must be direct and substantive, not incidental.
Similarly, a study on the cardiovascular side effects of the shingles vaccine in older adults has potential. However, if the paper is primarily a vaccine safety surveillance report, it belongs in a pharmacovigilance or geriatrics journal. To fit a cardiology scope, the analysis would need to focus on the incidence and management of specific cardiac events (e.g., myopericarditis), proposing new insights for cardiologists who may see these patients.
The corpus on West syndrome treatment illustrates another key point: prognosis depends heavily on underlying cause. In cardiology, a study on heart failure with preserved ejection fraction (HFpEF) that does not account for or stratify by major etiologies (hypertensive, ischemic, etc.) may be seen as insufficiently focused for a specialized journal. The editor perceives a "scope mismatch" because the analysis isn't granular enough for their readership's sophisticated understanding of disease subtypes.
The solution is not to change your data, but to reframe your narrative. Successful publication in clinical cardiology requires a clear through-line from your research question to a cardiologist's decision-making. Here is a practical framework:
A senior editor at a major cardiology journal once told me, "We reject studies 'about' a disease that happens to be in the heart. We accept studies that are 'about' heart disease, full stop."
Before your next submission, perform this audit. Write a single sentence: "This paper will change cardiology practice by demonstrating [X]." If [X] is:
"...a new biomarker for heart failure readmission," you're likely on-scope.
"...the role of a specific immune cell in inflammation," you are likely off-scope unless tightly linked to a cardiac outcome.
"...the systemic effects of Disease Y," you are definitely off-scope.
If your sentence doesn't pass, reframe the manuscript's emphasis. Sometimes, the best path is to target a more specialized journal (e.g., a journal of autoimmune diseases or neurocardiology) where your integrated approach is the core scope.